Benjamin is a business-minded and purpose driven leader in the pharmaceutical industry with a strong scientific background and cross-cultural experience. Through leadership roles and project assignments, he has gained experience across the pharmaceutical industry value chain and in all phases of drug development in the therapeutic areas respiratory, immunology, cardiovascular, metabolism and central nervous system.
At Boehringer Ingelheim (BI), Benjamin is leading a group of quantitative clinical pharmacologists that accelerate and streamline drug development by applying model-informed drug development approaches. His senior group members lead early clinical development teams and are responsible for delivering overall drug development strategies including biomarker and clinical pharmacology strategies to senior management committees. Previously, Benjamin was Head of Translational Medicine & Clinical Pharmacology Respiratory at BI.
Benjamin holds a Professional Degree in Pharmacy from University of Tuebingen, a Master of Statistics from University of Florida, an Executive Master of Business Administration from Quantic School of Business and Technology and a PhD in Pharmaceutical Sciences from University of Florida.
His transferable skills include making better decisions, asking the right questions at the right time, developing and leading individuals and groups, as well as developing and executing strategies in the pharmaceutical industry.
Benjamin was recognized with outstanding young alumni award “40 Gators Under 40” by the University of Florida. He published multiple articles in peer-reviewed journals and received invitations to present at academic institutions and international conferences.
He has a successful track record of applying situational leadership principles with direct reports and in a matrix environment. Benjamin is strongly convinced and a role model that a healthy work-life-balance is key for sustainable career success.